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Abstract
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The rates at which biological interactions occur can provide important information on the
mechanism and behavior of such processes in living systems. This review will discuss how
affinity chromatography can be used as a tool to examine the kinetics of biological interactions.
This approach, referred to here as biointeraction chromatography, uses a column with an
immobilized binding agent to examine the association or dissociation of this agent with other
compounds. The use of HPLC-based affinity columns in kinetic studies has received particular
attention in recent years. Advantages of using HPLC with affinity chromatography for this
purpose include the ability to reuse the same ligand within a column for a large number of
experiments, and the good precision and accuracy of this approach. A number of techniques are
available for kinetic studies through the use of affinity columns and biointeraction
chromatography. These approaches include plate height measurements, peak profiling, peak
fitting, split-peak measurements, and peak decay analysis. The general principles for each of these
methods are discussed in this review and some recent applications of these techniques are
presented. The advantages and potential limitations of each approach are also considered.
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1 Introduction
1.1 General principles of affinity chromatography
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The method of affinity chromatography has been used for decades as a selective means for
the purification and analysis of chemicals in biological systems [1-6]. Affinity
chromatography can be defined as a type of liquid chromatography in which a biologicallyrelated agent is used as the stationary phase [1,7]. This biologically-related agent, referred to
as the “affinity ligand”, can consist of an immobilized sequence of DNA or RNA, a protein
or enzyme, a biomimetic dye, an enzyme substrate or inhibitor, or a small target molecule,
among others [2]. The specific nature with which these ligands can interact with their targets
provides the basis for the selective separations that can be obtained when using affinity
chromatography, making this an important tool in modern biochemistry and chemical
analysis [1,3-6].
In the past, many affinity separations were conducted using low-performance supports such
as agarose or polyacrylamide [8]. However, HPLC media like silica and monolithic supports
can also be used as the support material in affinity separations, resulting in a technique
known as high-performance affinity chromatography (HPAC) [2,8-11]. Along with
*
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providing an efficient and rapid means of selective separation and analyzing chemicals in
complex biological samples, the development of HPAC has further resulted in a series of
new tools that can be used to study biological interactions. This review will examine the use
of affinity chromatography and HPAC in such studies, with particular attention being given
to the use of these methods in examining the rate constants and kinetics of biological
binding processes.
1.2 Biointeraction chromatography
The use of affinity chromatography to characterize a biological interaction is a method that
is referred to as biointeraction chromatography (also known as quantitative affinity
chromatography or analytical affinity chromatography) [12-16]. There are a number of
advantages to utilizing affinity chromatography, and especially HPAC, for studying
biological interactions. For instance, the immobilized ligand in an affinity column can often
be used for a large number of sample injections. This feature helps to provide optimum runto-run precision and minimizes batch-to-batch variations in the experiments because the
same preparation of ligand is used for multiple studies. The same feature reduces the total
amount of ligand that is needed for the experiments and lowers the cost when expensive
ligands such as monoclonal antibodies or cell receptors are used. In addition, biointeraction
studies that are conducted by using HPAC can be easily automated and used as the basis for
relatively high-throughput measurements [16].
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The proper use of biointeraction chromatography (and affinity chromatography in general)
does require that careful attention be given to the nature of the affinity ligand and the way in
which this ligand is used to study a biological interaction. Fortunately, many immobilization
techniques are available for this purpose (see reviews in Refs. [3-6,17]). In addition, it has
been shown for some biological systems that good agreement can be obtained in the binding
behavior of the immobilized and native forms of a ligand (e.g., as noted for drug-protein
binding in Refs. [15-17]). It is also now possible to physically entrap some ligands in a
support such as a sol gel to directly use the soluble form of a ligand in binding studies [17].
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Most past applications of biointeraction chromatography have involved its use in obtaining
information on binding equilibria and thermodynamics (see reviews and examples in Refs.
[12,15,16,18]). However, this technique can also be used to examine the kinetics of a
biological interaction. The kinetics of such a binding process can be studied by using one of
a pair of interacting agents as a ligand within an affinity column while the second,
complementary binding agent is injected or applied onto this column. The observed peak or
elution profile for the injected analyte is then used to provide information on the rate of the
analyte-ligand interaction. This general approach has been used examine the rates of several
biological systems, including antibody-antigen interactions, lectin/sugar binding, and drugprotein interactions, among others (see Table 1) [19-53].
Figure 1 depicts a common model used to describe the kinetic processes that lead to the
interaction of an analyte (A) with an immobilized ligand on a chromatographic support. In
this model, as the analyte travels through the column in the flowing mobile phase, the
analyte can undergo mass transfer from the flowing region of the mobile phase to a stagnant
layer of mobile phase that surrounds, and is contained within, the interior of each support
particle. This stagnant mobile phase mass transfer is described in Figure 1 by the forward
and reverse mass transfer rate constants k1 and k-1, respectively. Once the analyte is inside
of the support pores, it can then interact with the immobilized ligand that is in contact with
the stagnant mobile phase region. This interaction of A with L is represented in Figure 1 by
a simple 1:1 reversible interaction with association and dissociation rate constants given by
the terms ka and kd. The ratio of these rate constants in this model gives the association
equilibrium constant (Ka) for the formation of the analyte-ligand complex, where Ka = ka/kd.
J Sep Sci. Author manuscript; available in PMC 2009 November 25.
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The overall strength and rate of analyte-ligand binding will determine the types of methods
that can be used to characterize the interaction kinetics with biointeraction chromatography.
However, all of these methods are based on either the injection of a small plug of the analyte
(i.e., zonal elution) or the continuous application of an analyte (i.e., frontal analysis, or
frontal affinity chromatography). It is further possible to characterize these methods
according to whether they use a trace amount of applied analyte (i.e., linear elution
conditions, giving a result that is independent of the amount of injected analyte) or a
significant amount of analyte versus ligand (i.e., non-linear elution conditions, where the
response is affected by the amount of applied analyte) [54]. A variety of techniques that
cover all of these categories will be discussed in Sections 2-4 of this review.
1.3 Biointeraction chromatography versus surface plasmon resonance
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In considering the potential applications of biointeraction chromatography, it is useful to
also consider surface plasmon resonance (SPR), a technique which forms the basis for
affinity and kinetic measurements in instruments such as Biacore [15,55,56]. SPR-based
sensors are closely related to affinity chromatography in that they employ a flow-based
system to monitor the association and dissociation of an analyte from a surface that contains
an immobilized ligand. However, in SPR the interaction is examined directly within the
sensor and at the sensor's surface; in biointeraction chromatography the interaction is
examined through its affect on the retention or elution profile for an analyte, as observed at
the exit of the column [15]. Although a detailed discussion of SPR is beyond the scope of
this current review, a rigorous treatment of this topic can be found in a number of recent
reports [15,55,56].
In both SPR and biointeraction chromatography it is necessary to use the proper
experimental conditions and appropriate models or methods for data analysis to obtain
accurate rate constants. The conditions and models that should be used in biointeraction
chromatography have been discussed in previous reports [15-17], as well as in this current
review. Various mathematical treatments and systematic precautions to follow in SPR have
also been discussed in the past [55,57-61]. Both biointeraction chromatography and SPR
have similar considerations concerning the need to have an immobilized ligand that mimics
the binding behavior of the same ligand in its native state. It is also necessary in both to
make corrections for mass transfer to obtain accurate kinetic measurements for the binding
of an analyte with the ligand. If these requirements are met, either biointeraction
chromatography or SPR can be used successfully for examining the kinetics of biological
systems [56,62].
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One key difference between SPR and biointeraction chromatography is the way in which the
analyte-ligand interaction is detected and monitored. The use of surface plasmon resonance
to monitor such a reaction will give a signal that is proportional to the amount of analyte that
has been bound by the immobilized ligand. This signal, in turn, is related to the size of the
analyte, the concentration of the analyte, and the affinity of this analyte for the ligand
[56,63]. The nature of this signal can make it difficult to detect small analytes or to work
with analytes that are present at low concentrations [59,63,64], such as those that have
limited solubility in an aqueous buffer. It is possible to improve analyte concentration and
the corresponding signal in SPR by adding an organic modifier or solubilizing agent, but the
presence of this agent may also alter the nature of the analyte-ligand interaction [9,63].
Unlike SPR, biointeraction chromatography is not limited to a particular detection method
because the support/surface that contains the ligand is separate from the means used for
analyte detection. A large variety of detectors have been used in biointeraction
chromatography, with UV-Vis absorption spectroscopy, fluorescence spectroscopy, and
mass spectrometry being the most common. The greater range of detection modes and the
ability of these detectors to monitor lower concentration species than SPR make it easier to
J Sep Sci. Author manuscript; available in PMC 2009 November 25.
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use biointeraction chromatography with chemicals that are present at low concentrations,
that have low solubility or that have only weak to moderate affinities for a ligand.
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The ability to detect a binding curve with SPR does not necessarily mean that accurate rate
constants can be measured from this curve. The effect of rebinding and the balance between
mass transfer and chemical interaction kinetics in this approach places a limit on the
association and dissociation rate constants measurable by SPR [58,59]. Accurate and precise
kinetic measurements in SPR have typically been limited to systems with moderate to strong
binding (i.e., Ka = 105 M-1 or larger), with decreased precision being noted for systems with
weaker binding and/or those with fast association or dissociation kinetics [63,65]. On the
other hand, biointeraction chromatography has been used in several studies to examine the
kinetics of drug interactions with serum proteins, which often involve chemicals that may be
present at low concentrations or have binding constants in the range of 105 M-1 or lower (see
reviews in Refs. [15-17]). In contrast to this, little comparable work has been conducted with
SPR with this type of system and the work that has been done has involved only drugprotein interactions with relatively high affinities [63]. Many different approaches are
available in biointeraction chromatography to examine the kinetics of an analyte-ligand
interaction. Some of these approaches (e.g., frontal analysis) are similar to SPR in that they
make use of binding and saturation curves, while others make use of zonal elution profiles
or measurements of non-retained analyte fraction for such work. The availability of this
broad range of approaches makes it possible for biointeraction chromatography to be used in
examining a wide range of rate constants for analyte-ligand interactions.

2 Band-broadening measurements
The measurement and use of band-broadening was the earliest approach developed for using
affinity chromatography to study the kinetics of biological reactions. This type of study is
typically performed by using zonal elution and injections of small pulses of the analyte to
achieve linear elution conditions. Two specific approaches for kinetic studies by
biointeraction chromatography that are based on band-broadening measurements are the
plate height method and peak profiling.
2.1 Plate height method
The plate height method (also known as the band-broadening method) makes use of plate
height and band-broadening measurements to obtain information on the rate of an analyteligand interaction [19,31,53,66]. In this method the affinity column is viewed as being
divided into a series of equal sized regions (i.e., “theoretical plates”, N) that each represents
a single interaction between the analyte and stationary phase. According to chromatographic
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theory, the value of N is equal to the ratio

, where tR is the retention time observed

is
for the analyte, σR is the standard deviation of the elution profile for the analyte, and
the corresponding variance (Note: each of these terms should be corrected for extra-column
contributions, as measured by performing sample injections with no column present). The
distance along the column that makes up each theoretic plate is described by using the “plate
height” (H), where H = L/N and L is the total length of the column [66,67].
Several processes contribute to the broadening of a chromatographic peak as an analyte
travels through an affinity column. Each of these processes, in turn, can be described by its
own plate height term. For instance, the plate height contribution due to mobile phase mass
transfer and eddy diffusion (Hm) describes the broadening that occurs due to differential
migration paths and interparticle flow profiles. The plate height contribution due to the
longitudinal diffusion term (HL) describes broadening due to axial diffusion of solutes. Two
other important plate height contributions are those due to stagnant mobile phase mass
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transfer (Hsm) and stationary phase mass transfer (Hk), which are related to the mass transfer
and interaction processes, respectively, that were given in Figure 1. As shown in Eq. (1), the
total observed plate height for the analyte (Htotal) is equal to the sum of each of these
individual contributions to band-broadening, where the value of Htotal has already been
corrected for the plate height contribution due to extra-column band-broadening
contributions (Hec) through the measurements made when no column is present in the
system.

(1)

To make kinetic measurements in the plate height method, it is typically assumed that the
contribution of HL to the total plate height is negligible and that Hm is constant, as is often
true at the flow rates that are commonly used in affinity chromatography. The following
equations are then used to provide estimates of Hsm and Hk or to measure these terms from
independent band-broadening studies with retained and non-retained solutes, respectively
[66].
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Stationary phase mass transfer:

(2)

Stagnant mobile phase mass transfer:

(3)
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In these equations, u is the linear velocity of the flowing mobile phase (as measured using a
non-retained void marker capable of sampling all inter- and intraparticle space), VP is the
pore volume of the support, VM is the column void volume, k is the retention factor of the
analyte, and all other terms are as described previously. It is also useful to note that for a
non-retained solute (k = 0), Eq. (3) reduces to the following form [23,66].
For a non-retained solute (k = 0):

(4)

In the plate height method, the analyte of interest is first injected onto an inert control
column or a non-retained species is injected onto a column containing the desired ligand.
These injections are made at various flow rates to obtain plate height measurements at k = 0.
A plot of Htotal versus u is then made and examined by linear regression. An example of
such a plot is shown in Figure 2(a). The resulting best-fit parameters are then analyzed by
combining Eqs. (1) and (4). If the values of VP and VM are known for the column, as can be
J Sep Sci. Author manuscript; available in PMC 2009 November 25.
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determined from independent measurements, it is then possible to obtain k-1 from the bestfit slope. The value of Hm can also be estimated as being equal to the intercept of this plot
[31, 53, 66].
In the second step of this approach, injections of the analyte are made onto an affinity
column (at several flow rates) containing the desired immobilized ligand and both the total
plate height and retention factor are measured. The value of k-1 that was determined in the
first set of experiments is then used along with Eq. (3) and estimates of VP and VM to
estimate the value for Hsm at each of tested flow rates. These values for Hsm and the
previous estimate of Hm are then subtracted from the total observed plate height for the
analyte in Eq. (1) to give the plate height contribution due to stationary phase mass transfer
(Hk). Finally, a plot of the calculated value of Hk is made versus the term [u k/(1+k)2]. The
result, as predicted by Eq. (3), should be a plot with an intercept of zero, and a slope that can
be used to provide the dissociation rate constant for the analyte/ligand system [31,66]. This
type of plot is illustrated in Figure 2(b).
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The dissociation rate constant that is measured by the plate height method is identical to the
term kd that is shown for the general reaction model in Figure 1. This is the case because
other sources of band-broadening, such as mobile phase mass transfer and stagnant mobile
phase mass transfer, are corrected for during the data analysis process. It is also possible to
obtain the value of the association rate constant (ka) for this interaction if the calculated
value of kd is used along with an independent measure of the association equilibrium
constant Ka, since Ka = ka/kd. The value of Ka in this case can be obtained through separate
biointeraction studies that are based on frontal analysis or zonal elution, as previously
discussed in detail in Refs. [12,15,16].
An early application of the plate height method involved its use to examine the rates at
which various sugars bind to concanavalin A [19]. This technique has also been used to
measure the rate constants for interactions of R/S-warfarin and D/L-tryptophan with the
protein human serum albumin (HSA) [31,53]. The dissociation rate constants found for the
interactions of warfarin with HSA using the plate height method were in the same general
range but slightly smaller than those reported with racemic warfarin using stopped flow
analysis; however, this small difference was thought to be a result of the high concentrations
of warfarin used in the stopped flow analysis studies, which may have led to a larger
contribution from non-specific interactions [31]. A kinetic analysis of warfarin-HSA
interactions using SPR gave results that were in good agreement with those obtained via the
plate height method [31,63].
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The kinetic studies on tryptophan and warfarin were performed at several temperatures and
used along with separate estimates of Ka to obtain dissociation and association rate constants
for each of these temperatures. This information was then examined through the use of
Arrhenius-type plots to obtain more details on the kinetics and transition states for the
interactions of HSA with each solute. Similar work looking at the effects of pH, ionic
strength and solvent polarity on the association and dissociation kinetics were conducted for
D/L-tryptophan [31,53]. The information obtained from these studies was found to be
important in optimizing chiral separations for R/S-warfarin and D/L-tryptophan on HSA
columns [31,53]. This type of kinetic data has since been shown to be useful in describing
the pharmacokinetics of drugs that bind to HSA [68,69] and in developing new assays for
measurement of free drug or hormone fractions in serum [70,71].
The plate height method requires that the association and dissociation rates for the analyteligand interaction are reasonably fast to allow multiple binding and dissociation steps to
occur as the analyte passes through the affinity column. This requirement means that the
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plate height method is most useful for ligands that have weak-to-moderate strength binding
(i.e., Ka values that are 106 M-1 or lower). It is also necessary in this approach to ensure that
a sufficiently small amount of analyte is being injected to provide linear elution conditions.
The use of efficient columns and support materials is another desirable feature in this type of
experiment because this helps minimize the plate height contributions due to Hm and Hsm
and makes it easier to obtain estimates of Hk. In addition, it is important to measure and use
the true retention times and peak variances in these studies. A correction should also be
made for extra-column band-broadening and extra-column components to the observed
elution time by injecting the analyte onto the chromatographic system when all components
except the column are present [16,31,53].
2.2 Peak profiling
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An approach that is closely related to the plate height method is the technique of peak
profiling. This is another example of a method that is performed by using zonal elution and
linear elution conditions. A theoretical derivation for this approach in affinity
chromatography was first reported in 1975 by Denizot and Delaage, who based their work
on the molecular dynamic theory of chromatography that was previously developed by
Giddings and Eyring [72,73]. In the peak profiling method, the retention times and variances
are measured on an affinity column for both a retained analyte and a non-retained solute (see
Figure 3). In the original peak profiling method, these values were then used with the
following equation to calculate the apparent dissociation rate constant (kd,app) for this
interaction [72],

(5)

In Eq. (5), tR is again the retention time for the analyte and tM represents the elution time of
a non-retained solute (i.e., the column void time). The peak variances for the analyte and
non-retained solute are described by the terms
and , respectively. Although this
method is relatively simple to perform, it does assume that all sources of band-broadening
other than stationary phase mass transfer are either negligible or the same for the retained
and non-retained species. It is for this reason that Eq. (5) is shown as providing an apparent
dissociation rate constant (kd,app), which may be affected by some of these other bandbroadening processes.
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An early application of the original peak profiling method was its use in studying the
kinetics of bovine neurophysin II (BNP II) self-association and the binding of BNP II with
the neuropeptide Arg8-vasopressin (AVP). These experiments utilized BNP II that was
immobilized on either non-porous or porous glass beads. However, it was found that the rate
constants determined by this approach were underestimated by orders of magnitude
compared to solution phase values, especially when using porous supports [49,74]. This
difference may have been due to differences in the stagnant mobile phase mass transfer
contributions for the retained and non-retained species or the use of relatively low flow rates
and fraction collection for these experiments. Later, a mathematically equivalent approach
employing plate height measurements was used with HPAC to examine the dissociation
kinetics of sugars on an immobilized concanavalin A column [38]. Further analysis of this
system indicated these results were also underestimated due, in part, to working under nonlinear conditions [38,52]. Later work with this approach used measurements at high flow
rates to examine the binding of L-tryptophan with HSA that was immobilized to a
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monodisperse HPLC support material; in this case, reasonably good agreement was obtained
with literature values [50].
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A modified form of the peak profiling method has recently been developed that uses HPAC
and work at multiple flow rates for band-broadening measurements. An alternative form of
Eq. (5) was developed for this work, which was now expressed in terms of the plate heights
for the retained and non-retained species (HR and HM), the retention factor for the retained
species, and the linear velocity of the mobile phase, as shown below [47].

(6)
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Eq. (6) was found to be useful for peak profiling studies because it predicts that a plot of
(HR - HM) versus [u k/(1+k)2] will give a linear relationship with a slope that can be used to
provide the value of kd,app (see Figure 4). The results of this approach were compared to
those obtained by traditional peak profiling at a single linear velocity by using L-tryptophan
and HSA as a model system. It was found that the traditional method gave kd,app values that
varied with linear velocity, while the use of Eq. (6) and data obtained at multiple linear
velocities allowed for more precise and accurate estimates of dissociation rate constants
[47]. An expanded form of this approach that includes a correction for non-specific binding
processes has also been used to study binding kinetics of HSA with imipramine and
propranolol [48].
One advantage of using multiple flow rates for peak profiling is that Eq. (6) can be expanded
to correct for the contribution of stagnant mobile phase mass transfer. The expression that is
used for data analysis in this case is given by Eq. (7) [47].

(7)
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In this equation, dP is the particle diameter of the support packing material, γ is the
tortuosity factor, and D is the diffusion coefficient of the analyte in the mobile phase. This
expression has been used to determine the dissociation rate constant for the L-tryptophan/
HSA system by using a series of columns that contained supports with different particle
diameters. In this method, a series of plots are made of HR-HM versus [u k/(1+k)2] for a
group of columns that have different values for dp. The best-fit of these plots are then
determined and used to prepare a second graph in which the resulting best-fit slope is plotted
versus dp2. It is then possible from the intercept of this new graph to obtain the true
dissociation rate constant (kd) for the system [47].
Peak profiling is similar to the plate height method in that it works best with a solute-ligand
system that has relatively fast rates of association and dissociation rates and weak-tomoderate strength binding. It is also again necessary to do this type of experiment under
linear elution conditions and to correct for extra-column contributions to band-broadening
and elution times. In addition, the use efficient columns and support materials again helps to
minimize plate height contributions other than Hk, providing for easier measurements of
dissociation rate constants. An advantage of the peak profiling method is that it can allow
for higher-throughput kinetic measurements than the plate height method because it can be
conducted at higher flow rates [47,48,50]. However, the use of higher flow rates also
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requires a fast sampling rate for data to minimize the effect of any electronic dampening on
the measured peak variances.
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It can be seen from this discussion and the previous section that there are many similarities
between the peak profiling and plate height methods. This similarity is a result of the fact
that the peak profiling method is essentially a subset of the plate height method which uses
higher flow rates and a more direct calculation method. In the plate height method, the void
marker is used to gain information on the factors that contribute to band broadening, where
each contribution is calculated or measured and subtracted from the total plate height for an
analyte. In peak profiling several band-broadening factors are dealt with simultaneously by
comparing the total plate height that is measured for the analyte with that measured for a
non-retained solute. Both methods should yield comparable results and are capable of
correcting for mass transfer contributions, but the peak profiling method has the possibility
of allowing for faster data collection and analysis.

3 Peak fitting methods
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Although the plate height and peak profiling methods both use dilute amounts of analyte and
linear elution conditions, similar methods have also been developed that allows the use of
much higher analyte concentrations in such work (i.e., non-linear elution conditions). The
advantage of using non-linear conditions is that the high concentrations of applied analyte
make it possible to have easier analyte detection. Non-linear peak fitting is one approach
that can be used for kinetic measurements of analyte/ligand kinetics under such conditions.
Techniques have been described for such experiments that make use of either zonal elution
or frontal analysis, as will be discussed in this section.
3.1 Peak fitting in zonal elution
Peak fitting has been used with zonal elution to study analyte-ligand kinetics in work
conducted under non-linear elution conditions. This work has been conducted by using the
following equation to fit elution profiles [52,75].

(8)

NIH-PA Author Manuscript

This equation is written in a form in which y represents the intensity of the measured signal
at a given point in time in the elution profile, x is the reduced retention time at which y is
measured, T is a switching function, and I1 is a modified Bessel function. The terms a0
through a3 are the best-fit parameters used to fit this equation to the experimental peak.
These parameters are then used, in turn, to estimate the value of the rate constants and
equilibrium constant for the analyte-ligand interaction. For instance, the values of k, kd,app,
and Ka can be determined by using the relationships k = a1, kd,app = 1/a2tM, and Ka = a3/Co,
where tM is the column void time and Co is the concentration of injected solute multiplied
by the ratio of sample volume to column dead volume [35].
An example of the peak shape and experimental fit that can be expected from this type of
experiment is given in Figure 5. This fit is based on the same general non-linear model that
is often used in fitting frontal analysis data in biointeraction chromatography (see next
section); however, the difference in these two approaches is that Eq. (8) uses an impulse
input to model sample application in order to obtain a zonal elution profile [52]. The fit of
this model in Figure 5 and in related applications tends to be best early in the elution profile
J Sep Sci. Author manuscript; available in PMC 2009 November 25.
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but not quite as good towards the tail of a peak. Ligand heterogeneity has been cited as the
cause for these observed deviations at the peak tail [52]. Despite these deviations, the
resulting fit has been found in one study to be sufficient to allow the relative ranking of
compounds according to their dissociation rates, which correlate with the duration of an
inhibitory effect [34].
Eq. (8) was original developed and used to study the binding of pNp-mannoside binding to
an immobilized concanavalin A column [52]. This equation has also been used to
characterize the binding of various inhibitors to immobilized nicotinic acetylcholine receptor
(nAChR) membrane affinity HPLC columns [25-28,34,35]. These experiments have been
used to estimate both the binding constant and rate constants for these interactions, as well
as to develop quantitative-structure activity relationships (QSARs) for these inhibitor/
nAChR interactions. This approach has also been used to perform studies on immobilized
heat shock protein 90, a molecular chaperone protein that has been noted to have increased
activity in some types of cancer [33].

NIH-PA Author Manuscript

An expression similar to Eq. (8) was derived to describe peak shapes for the non-specific
elution of an otherwise irreversibly retained solute [30]. This alternative equation was then
used to fit data obtained for the use of a pH step gradient to elute human IgG-class
antibodies from a column containing protein A that was immobilized onto non-porous silica.
A good fit between the experimental data and best-fit peaks was obtained, giving an
estimated dissociation rate constant of 1.5 s-1 for IgG from protein A in the presence of a pH
3.0 buffer [30]. The same technique has also utilized in examining the elution of lysozyme
from a Cibacron Blue 3GA columns in the presence of elution buffers that contain various
concentrations of sodium chloride [29].
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An advantage of this peak fitting approach is that it does not require the use of linear elution
conditions. The utilization of Eq. (8) for this approach assumes that the interaction being
monitored has reasonably fast association/dissociation kinetics, which generally means that
the system has weak-to-moderate binding. However, the method reported in Ref. [30] can
allow this method to also be used with high affinity systems under mobile phase conditions
that allow for measurable analyte dissociation. One precaution with the use of these
equations is that they do assume that the contribution of some kinetic processes are
negligible compared to analyte binding and/or dissociation form the ligand. For instance, the
past use of Eq. (8) for kinetic studies has treated stagnant mobile phase mass transfer as a
contributing factor to the measured rate constant instead of treating this as a separate entity.
Similarly, work in Refs. [29,30] that has examined analyte dissociation kinetics from affinity
columns has assumed that the contribution of stagnant mobile phase mass transfer to the
apparent rate of analyte desorption is negligible. It is for this reason that the rate constants
determined by this technique are typically apparent values that are actually a function or
more than one kinetic process occurring within the column.
3.2 Peak fitting in frontal analysis
Frontal analysis can also be used with peak fitting to examine the kinetics of solute-ligand
interactions by affinity chromatography. A substantial amount of work has been performed
in this area using low-performance supports for affinity chromatography,[76-79] however,
this current review will focus on applications using HPAC. Many of the models and
expressions that are used for this purpose are based on the initial work of Thomas [75]. This
model gives an apparent rate constant for analyte adsorption to the column (ka,app), in which
it is assumed that mass transfer is infinitely fast and analyte adsorption is described by
second-order Langmuir kinetics based on interaction at a single type of homogeneous ligand
binding site [32,54,75]. Numerous variations of this model have been used, but in each the
simulated frontal profiles are compared with experimental results to estimate ka,app. For
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example, work examining the adsorption of lysozyme to a Cibacron Blue F3GA column
with a non-porous support used a general Langmuir adsorption model but treated mass
transfer as a film resistance mechanism [32]. Simulated profiles were then used to examine
the effects of particle diameter, concentration, flow rate, and association rate constants on
the expected profiles and compared to experimental results to determine the apparent
association rate constants for adsorption. The simulated profiles showed good correlation
with experimental breakthrough curves at the application front, but ligand heterogeneity was
thought to decrease the goodness of fit near the plateau region [32].
The binding of HSA to columns containing immobilized anti-HSA antibodies was examined
by using frontal analysis along with a Langmuir adsorption model and a rectangular
isotherm, in which dissociation of the analyte was assumed to be negligible on the timescale
of the experiment (i.e., kd was essentially zero) [43]. This model gave a good fit with
experimental breakthrough curves at low HSA concentrations, however, a flow rate
dependence of the measured apparent association rate constant was observed due to the
contribution of mass transfer. Apparent association rate constants were determined on
columns of various load capacities and used along with the following equation to correct for
such contributions.
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(9)

In this equation, nmt is a global mass transfer coefficient that is dependent on the packing
and column dimensions, F is the flow rate, VM is the column void volume, and qx is the
loading capacity of the column. A plot of 1/ka,app versus qx was then prepared, and the
intercept used to calculate the true association rate constant ka for the HSA-antibody
interaction, giving results in good agreement with those reported in the literature [43]. A
similar approach for correcting for mass transfer contributions has been utilized to study the
interaction of fibrinogen with immobilized peptides [21].
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A bi-Langmuir model based on two independent binding sites has been employed in some
studies to examine the rates of analyte-ligand interactions by frontal analysis. This type of
model has been employed to compare the adsorption of HSA to various columns [24] and to
describe the adsorption of β-lactoglobulin to immobilized antibodies for this protein [41]. In
this latter study, it was found that β-lactoglobulin/antibody interaction was not irreversible
on the timescale of the experiment, making it impossible to determine equilibrium constants
under such conditions. This led instead to the development of an approach making use of
sequential frontal applications of the analyte that were separated by a rinsing step of a
predefined duration [42]. During this rinsing step some, but not all, of the adsorbed analyte
was able to desorb as a function of the dissociation rate constant, affecting the results of the
second frontal application. Figure 6 demonstrates how the breakthrough time of the second
frontal application was reduced compared to the initial application. Column saturation
occurred more quickly in the second application because some binding sites were already
filled due to incomplete desorption following the first application and rinsing step. A biLangmuir adsorption model was then fit to these curves to provide the apparent association
and dissociation rate constants for this system [42].
Another variation on the frontal analysis approach has involved the use of linear
chromatographic theory to determine concentration-dependent rate constants, and then to
extrapolate these values to those that would be expected at infinite dilution. This technique
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makes use of the following equation that is true under linear elution conditions
[15,40,80-82],
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(10)

Where VA is the measured breakthrough volume for the analyte, and VA* is the
breakthrough volume for a non-retained solute, F is the flow rate, and
the breakthrough curve. A plot of

is the variance of

versus F is prepared for data obtained at a range of

. The effects of slow mass transfer in
flow rates and gives a slope which yields
this experiment can be corrected empirically by making analyte injections on a column that
does not contain any immobilized ligand [40] or by using an exact analytical solution [39] to
obtain the corrected value of

. This process is done over a range of concentrations
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and the resulting values of
are then each used to calculate an apparent value for the
dissociation rate constant, kd,app. These values for kd,app are then analyzed as a function of
the applied concentrations and extrapolated to infinite dilution to give the true value of kd.
This approach has been used to examine the binding of p-nitrophenyl-α-D-mannopyranoside
with immobilized concanavalin A [39,40].
The advantages and disadvantages of using peak fitting in frontal analysis are similar to
those noted in the previous section for zonal elution. This approach again does not require
the use of linear elution conditions; however, it does make certain inherent assumptions
about the kinetics of the system that is being monitored. Examples of these assumptions are
that the data fits a certain type of adsorption isotherm (e.g., a Langmuir or bi-Langmuir
model) and that the effects of stagnant mobile phase mass transfer are negligible compared
to the rates of solute association and/or dissociation with the immobilized ligand. The
presence of these assumptions means that the rate constants that are measured through this
approach will actually be apparent values that may vary with the experimental conditions. In
addition, although frontal analysis tends to be easier to perform than a zonal elution
experiment, this method can also require a larger amount of analyte.

4 Miscellaneous methods
NIH-PA Author Manuscript

A number of other techniques have also been developed for examining the kinetics of
solute-ligand interactions by affinity chromatography. Examples include the split-peak
method and peak decay analysis. The principles behind each of these approaches will now
be examined, as well as their applications. The combined use of these two methods will also
be examined.
4.1 Split-peak method
The split-peak method can be used to examine affinity interactions in which there is
essentially irreversible binding of a solute with a ligand on the timescale of application step.
This approach is based on the idea that there is a given probability during any separation
process that a small fraction of analyte will elute non-retained from the column without
interacting with the stationary phase. This phenomenon is known as the “split-peak effect”.
This effect increases as the flow rate of application is increased or as the residence time for
the analyte in the column decreases, as illustrated in Figure 7 [83]. The result is two peaks
even for the injection of a pure solute onto an affinity column.
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The following equation has been derived to describe the split-peak effect for work under
linear elution conditions. This equation shows how the presence of either slow mass transfer,
as represented by 1/(k1Ve), or slow adsorption, represented by 1/(ka mL), will affect the free
fraction (f) of a solute that elutes non-retained from the column.

(11)
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In this equation, F is the flow rate of sample application, mL is the active moles of
immobilized ligand or binding sites in the column, and Ve is the excluded (interparticle)
volume of mobile phase in the column. The term k1 is the forward mass transfer rate
constant, and ka is the association rate constant for analyte-ligand binding, as defined earlier
in Figure 1 [23]. Eq. (11) can be used for rate constant measurements by first making a plot
of -1/ln f versus F for each tested analyte concentration. The size of this slope for any given
concentration of applied analyte may depend on the type of column and support that is used
in such an experiment, as shown in Figure 8. Figure 8 also shows the typical sample size
dependence of these plots, in which measured slope increases as larger amounts of an
analyte are used in the study; a correction for this effect can then be made by extrapolating
these measured slope to an infinitely dilute sample [23, 66]. Either mass transfer or
adsorption may be the rate-limiting step in analyte retention and dominate the extrapolated
slope term in Eq. (11) [23,46,84]. For some systems, the rate-limiting step can also be
identified by comparing the measured slope with independent estimates of the mass transfer
contribution for the analyte [23,66].
A split-peak method based on Eq. (11) was originally used by Hage et al. to study the
binding kinetics of rabbit IgG on various affinity columns containing immobilized protein
A. The results suggested that the rate limiting process for analyte retention of these columns
was dependent on the type of support and immobilization method that was being used [23].
This information made it possible to determine the apparent rate constant for IgG binding to
protein A and to optimize the performance of protein A affinity supports for the analysis of
clinical samples [23,66,85]. Computer simulations have been used to predict the response of
this method as a function of sample load for a homogeneous ligand under both mass
transfer- and adsorption-limited conditions [22], as well as the effect of sample load for the
adsorption-limited case in the presence of a heterogeneous ligand for columns that contained
mixtures of protein A and protein G [46].
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It is possible in some cases to obtain an exact solution for the split-peak effect under nonlinear elution conditions. The most common example is given in Eq. (12), which has been
derived in various forms to describe the binding of an analyte to a homogeneous ligand
under adsorption-limited conditions [44-46,51,84,86].

(12)

The term Load A is the relative moles of solute applied versus the total moles of active
ligand in the column, and So is a combination of system parameters, where So = F/(ka mL).
This method has been employed to study the binding kinetics of HSA to various types of
anti-HSA antibodies [44,45,51]. Such kinetic measurements have also been combined with
studies of epitopes and equilibrium constants to obtain a more complete picture of the
antibody interactions with HSA [51].
J Sep Sci. Author manuscript; available in PMC 2009 November 25.

Schiel and Hage

Page 14

NIH-PA Author Manuscript

Eq. (12) has also been used in the derivation of equations to describe the response of
chromatographic-based competitive binding immunoassays that are based on the split-peak
effect [84, 87, 88], as illustrated in Figure 9. In this example, a sample of HSA was injected
onto an anti-HSA column, followed by an injection of a fixed and known concentration of
HSA (used in this case as a “label”). A plot was then prepared based on the ratio of the
measured quantity of the label that was bound by the column following the injection of the
sample (B) versus the amount of bound label in the absence of any injected sample (Bo). The
resulting calibration plot of B/Bo versus log[analyte] gave a good fit with the response that
was predicted based on an expression derived from Eq. (11). This fit also made it possible to
estimate the association rate constant for the HSA/anti-HSA system and provided a result
that was in good agreement with values reported for other antigen/antibody interactions [84].
A similar approach based on Eq. (11) has been used with frontal analysis to measure the
apparent association rate constants for 2,4-dichlorophenoxyacetic acid (2,4-D) and related
herbicides to immobilized monoclonal anti-2,4-D antibodies [89,90] and the binding of Lthyroxine to anti-thyroxine antibodies and aptamers [37].
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An important advantage of using the split-peak method for rate constant determinations is it
requires only area measurements. This latter feature makes this method attractive because
peak areas are much easier to measure than peak variances or profiles, as are required in the
other techniques discussed previously in this review. The main limitation of this approach is
it is limited to analytes that have relatively slow dissociation kinetics, which typically
indicates the presence of high affinity interactions. It can also be difficult with some types of
affinity columns to reach appropriate experimental conditions to observe the split-peak
effect. Eqs. (11) and (12) indicate that the extent of this effect will increase as the
application flow rate is raised, as the column size is decreased, or as the amount of active
ligand in the column is decreased. All of these changes act to lower the probability of any
given analyte being retained by the affinity column and will increase the likelihood that a
measurable free fraction will be observed.
4.2 Peak decay method
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The peak decay method is another technique for rate constant measurements in
biointeraction chromatography. As its name implies, this approach is performed under
conditions in which part of the analyte elution profile gives a decay curve that can be related
to the dissociation rate for the analyte from the column. This method was originally
performed by injecting a small pulse of analyte on the column, followed by continuous
application of a high concentration of a competing agent that prevented any momentarily
dissociated analyte from rebinding to the ligand. This created a situation in which the
analyte washed from the column as it dissociated from the ligand. The result was a decay
curve that could be used under appropriate experimental conditions to estimate the
dissociation rate constant for the analyte-ligand system. High flow rates are typically utilized
during this experiment to minimize the effect of mobile phase mass transfer kinetics on the
decay profile and to lower the chance that the dissociated analyte will rebind to the
immobilized ligand [66].
The peak decay method and theoretical basis of this approach were first reported in 1987 by
Moore and Walters [36]. This work was followed by computer modeling studies which
examined conditions that were needed to obtain accurate dissociation rate constants through
this method [66]. In the case where analyte dissociation is slower than mobile phase mass
transfer, Eq. (13) can be used to find the apparent dissociation rate constant for the analyte.
This involves collecting data on the elution profile for the analyte from the column and then
determining the slope of this elution profile by plotting the natural logarithm of the peak
response versus time [36].
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(13)

In this equation, mEe represents the moles of analyte that elute from the column at any given
time, and mEo is the initial moles of analyte that were bound to the column. Other terms in
this equation are the same as defined earlier. This expression indicates that a plot of
ln(dmEe/dt) versus t should result in a linear relationship with a slope of −kd, which provides
the dissociation rate constant for the analyte/ligand system, as illustrated at the bottom of
Figure 10.
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The peak decay method was first used to examine the dissociation of 4-methylumbelliferylα-D-mannopyranoside (MUM) from immobilized concanavalin A. Figure 10(a) depicts the
elution profile that was observed for MUM as this analyte was eluted after a step change
was made to pass through the column a mobile phase that contained a fixed concentration of
mannose as a competing agent. After the response of this elution profile was converted to a
logarithmic scale, as shown in Figure 10(b), the new plot of this data was analyzed
according to Eq. (13) to find the dissociation rate constant from the slope of the central
linear region of this graph. It was found that the peak decay method allowed for accurate and
precise dissociation rate constants to be obtained for this system as long as sufficiently high
competing agent concentration and flow rates were used [36].
One limitation of this original technique is that it required the use of a competing agent for
analyte elution. This factor limits the usefulness of this method to systems in which the
competing agent and analyte have significantly different signals that can be monitored for
selective measurement of the decay profile. It has recently been shown that the peak decay
method can also be used with weak to moderate affinity systems without requiring any
competing agent. This was accomplished by using short affinity columns (e.g. 2.5 mm in
length) and high flow rates to reduce the probability of analyte re-association to the point
where no competing agent was necessary. This non-competitive peak decay method was
used to measure the dissociation rates of R/S-warfarin from immobilized HSA and gave
comparable results to previous rate constant measurements for this system [20]. The peak
decay method has also been used to estimate dissociation rate constants for analytes from
immobilized ligands in the presence of a step change in the pH of the mobile phase, as has
been demonstrated in work looking at the conditions needed to release 2,4-D and related
agents from anti-2,4-D antibodies [89,90].
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The peak decay method can be used with either weak or moderate affinity analytes, making
it complementary to the split-peak method [20]. The peak decay method can also be
employed in the identifying conditions for the elution of analytes from ligands with high
binding affinity [89,90]. The main disadvantage of the peak decay method is that it requires
the presence of experimental conditions that cause analyte dissociation from the ligand to be
the rate-limiting step in desorption of analyte from the column. Factors that can be adjusted
to help create such a condition are the elution flow rate, the column size, the type of support
material and (if a competing agent is to be used) the concentration of the competing agent.

5 Concluding remarks
This review has demonstrated how affinity columns and the method of biointeraction
chromatography can be a valuable tool in studying the kinetics of biological interactions.
Particular emphasis was given to methods that combine affinity ligands with HPLC columns
for this type of analysis. Important advantages of affinity columns and HPLC to examine the
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kinetics of biological systems include the ability of this approach to reuse a biological ligand
for a large number of experiments, and the good precision and accuracy of this approach.
This approach is complementary to SPR in terms of its ability to measure kinetics for
moderate to strong affinity systems. However, biointeraction chromatography is also
capable of working with systems that involve small analytes, weak binding or relatively fast
association/dissociation kinetics. Increasing the flow rate and reducing ligand density in
SPR (i.e., to reduce mass transfer and rebinding effects) can be used to examine small
analytes or those with weak binding to a ligand, but the reliability and reproducibility of
kinetic measurements in SPR are affected by such modifications [58]. The efficiency of
modern HPAC columns and the speed at which they can be used represent other advantages
of biointeraction chromatography as a tool for characterizing biological interactions.
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A variety of approaches for studying the kinetics of biological interactions have been
reported for use with affinity columns (see summary in Table 2). These approaches have
included those that are based on plate height measurements, peak profiling, and peak fitting,
as well as techniques that make use of the split-peak effect or peak decay analysis. These
methods have made it possible to perform kinetic studies for systems that range from weakto-moderate affinities to those with high affinities. Some of these methods are performed
under linear elution conditions (e.g., plate height measurements and peak profiling), while
others can be used under non-linear conditions (e.g., peak fitting in zonal elution or frontal
analysis methods). The range of methods that are available in biointeraction chromatography
is another advantage of this technique that allows kinetic parameters for nearly any analyte/
ligand system to be measured.
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A variety of applications for kinetic analysis by biointeraction chromatography were
discussed in this review. Some examples included the use of this method to examine the
interactions of drugs with proteins, sugars with lectins, receptors with their inhibitors, and
antibodies with various antigens. This range of systems should continue to grow as new
techniques are developed in this field and as more work is conducted to obtain a better
understanding of the theoretical and practical aspects of such studies. Recent correlation of
inhibitory effects and rate constants measured using bioaffinity chromatography have shown
the promise of this method as a tool for the selection of lead drug candidates and in
developing quantitative-structure activity relationships useful for drug discovery and
development [28]. In addition, kinetic measurements for serum-protein binding can assist in
prediction of the pharmacokinetic properties of drug candidates and in optimizing chiral
separations of drugs [31,53,69]. It is expected from current trends that the future will see an
even greater use of affinity columns and biointeraction chromatography as a valuable tool in
examining the kinetics of biological interactions for pharmaceutical development and
optimizing separations utilizing immobilized ligands.
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AVP

Arg8-vasopressin

BNPII

bovine neurophysin II

2,4-D

2,4-dichlorophenoxyacetic acid

HPAC

high-performance affinity chromatography

HSA

human serum albumin

MUM

4-methylumbelliferyl-α-D-mannopyranoside

nAChR

nicotinic acetylcholine receptor

QSAR

quantitative-structure activity relationship

SPR

surface plasmon resonance

a0…a3

Non-linear peak fitting parameters for zonal elution

B

Quantity of label bound in a competitive binding assay in the presence of
sample

Bo

Quantity of label bound in a competitive binding assay in the absence of
sample

Co

Concentration of injected solute multiplied by the ratio of sample volume to
the column dead volume

D

Diffusion coefficient for a solute in the mobile phase

dp

Particle diameter of a support material

f

Fraction of solute eluting free, or non-retained, from a column

F

Flow rate

I1

Modified Bessel function used in peak fitting

H or Htotal

Total plate height

Hec

Plate height contribution due to extra column band-broadening

Hk

Plate height contribution due to stationary phase mass transfer

HL

Plate height contribution due to longitudinal diffusion

Hm

Plate height contribution due to mobile phase mass transfer and eddy
diffusion

HM

Total plate height for a non-retained species

HR

Total plate height for a retained species
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Hsm

Plate height contribution due to stagnant mobile phase mass transfer

k

Retention factor

k1

Rate constant describing movement of a solute from the flowing mobile
phase to the stagnant mobile phase

k-1

Rate constant describing movement of a solute from the stagnant mobile
phase to the flowing mobile phase in a column

Ka

Association equilibrium constant

ka

Association rate constant

ka,app

Apparent association rate constant

kd

Dissociation rate constant

kd,app

Apparent dissociation rate constant

L

Column length

Load A

Relative moles of applied solute versus the total moles of active ligand

mEe

Moles of analyte eluting for a column at a given time

mEo

Initial moles analyte bound to a column

mL

Moles of active ligand

N

Number of theoretical plates

nmt

Global mass transfer coefficient

qx

Column loading capacity

So

Split-peak constant, where So = F/(ka mL) for a homogeneous ligand

T

Switching function

tM

Column void time

tR

Retention time for an analyte

u

Linear velocity of the mobile phase

VA

Breakthrough volume for a retained analyte during frontal analysis

VA*

Breakthrough volume for a non-retained solute during frontal analysis

VM

Column void volume

VP

Pore volume within a column

Ve

Excluded volume of mobile phase within a column

x

Reduced retention time in peak profiling

y

Signal intensity at a given time in peak profiling

γ

Tortuosity factor

σM

Standard deviation for the peak of a non-retained solute

σM2

Variance for the peak of a non-retained solute

σR

Standard deviation for the peak of a retained analyte

σR

2

Variance for the peak of a retained analyte
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Figure 1.

General model for describing the association and dissociation of an analyte with an
immobilized ligand in an affinity column, and the movement of this analyte through mass
transfer between the flow mobile phase and stagnant mobile phase regions of the column.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
J Sep Sci. Author manuscript; available in PMC 2009 November 25.

Schiel and Hage

Page 22

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 2.

Typical results obtained in the plate height method at several temperatures for (a) plots of
the total plate height (Htot) versus linear velocity (u) for the injection of R-warfarin onto an
immobilized HSA column, and (b) the corresponding plots of the plate height contribution
due to stationary phase mass transfer (Hk) versus u k/(1+k)2 after correcting the data for
other band-broadening contributions. (Adapted with permission from Ref. [31])
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Figure 3.

General approach used in peak profiling for obtaining kinetic information on a solute-ligand
interaction. In this figure, tM is the column void time (or elution time for a non-retained
solute), tR is the retention time for a retained analyte, σM is the standard deviation of the
peak for the non-retained solute, and σR is the variance of the peak for the retained analyte
(Note: the corresponding peak variances would be σM2 and σR2, respectively). These
parameters are typically measured in peak profiling by using peak fitting software and an
exponentially-modified Gaussian model. The set of three chromatograms shown for the nonretained and retained species represent results that were obtained at three different flow
rates.
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Figure 4.

Peak profiling plots prepared according to Eq. (6) for data obtained on an immobilized HSA
column for R/S-propranolol.
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Figure 5.
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A chromatogram and results of peak fitting according to Eq. (8) for the elution of verapamil
from a column containing an immobilized nicotinic acetylcholine receptor. The upper
tracing shows both the experimental data and initial fit to this data, while the lower tracing
shows just the best-fit response after a correction has been made for the baseline. (Adapted
with permission from Ref. [34])
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Figure 6.

Comparison of two sequential breakthrough curves for the binding of β-lactoglobulin to an
affinity column containing antibodies against this agent. The dashed lines show the
experimental data and the solid lines show the results obtained through peak fitting to a biLangmuir kinetic model. Each curve in this figure begins when a step change is made to
apply a sample solution to the column. (Adapted with permission from Ref. [42])
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Figure 7.

An illustration of the split-peak effect, as observed during the injection of rabbit IgG onto an
immobilized protein A column at several flow rates. The sample was injected at the first
arrow in each chromatogram and the retained analyte was eluted by a pH change at the
second arrow. (Adapted with permission from Ref. [83])
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Figure 8.
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Analysis of data obtained for split-peak studies, as analyzed according to Eq. (11). These
results show plots that were obtained for the binding of rabbit IgG to protein A columns in
experiments that involved the use of various sample sizes; the Schiff base (SB),
carbonyldiimidazole (CDI) or ester amide (EA) immobilization methods; and 10 μm
diameter support materials with pore sizes of 50 or 500 Å. The conditions for each plot were
as follows: SB method, 500 Å pore size, 22 μg IgG (○); SB method, 500 Å pore size, 11 μg
IgG (●); SB method, 50 Å pore size, 15 μg IgG (▲); CDI method, 500 Å pore size, 2.7 μg
IgG (■); and EA method, 500 Å pore size, 8.2 μg IgG (◆). (Adapted with permission from
Ref. [23])
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Figure 9.

A calibration curve for a sequential addition, competitive binding immunoassay performed
using HSA as the analyte and immobilized anti-HSA antibodies as the ligand in an affinity
column. The ratio B/Bo represents the relative fraction of a known quantity of labeled HSA
that was bound to the column with or without the previous injection of an unlabeled analyte
sample. The symbols represent the experimental results, while the line is the best-fit
response that was used to estimate the association rate constant for this interaction.
(Reproduced with permission from Ref. [84])
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Figure 10.

Examples of (a) a typical peak decay curve and (b) a logarithmic transform of this curve as
determined for elution of the sugar methylumbilliferyl α-D-mannopyranoside (MUM) from
an immobilized concanavalin A column after a step change was made to the continuous
application of 0.1 M mannose as a competing agent. These chromatograms were collected
on a 6.3 mm × 2.1 mm i.d. column at 10 mL/min. The slope of the curve in (b) was analyzed
according to Eq. (13) to obtain the dissociation rate constant for MUM from this column.
(Adapted with permission from Ref. [36])
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Table 1

Examples of applications of biointeraction chromatography in kinetic studies

NIH-PA Author Manuscript

Ligand

Analyte [Refs.]

Human serum albumin

Imipramine [48], R/S-propranolol [48], D/L-tryptophan [47,50,53] R/S-warfarin [20,31]

Antibodies

2,4-Dichlorophenoxyacetic acid and related herbicides [37], human serum albumin [24,43-45,51], βlactoglobulin [41,42]

Concanavalin A

4-Methylumbelliferyl-α-D-mannopyranoside [19,36], p-nitrophenyl-α-D-mannopyranoside
[19,36,38-40,52]

Protein A and protein G

Human IgG [30], rabbit IgG [22,23,46]

Cibacron Blue 3G-A

Lysozyme [29,32]

Nicotinic acetlylcholine receptors

Various inhibitors [25-28,34,35]

Heat shock protein 90

Novobiocin [33]

Bovine neurophysin II

Vasopressin [49]

Peptides

Fibrinogen [21]
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Table 2

Summary of methods for kinetic measurements by biointeraction affinity chromatography
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Method

Application conditions

Usable range of affinitiesa

Information obtainedb

Plate height measurements

Linear zonal elution

Weak to moderate affinity

kd

Peak profiling

Linear zonal elution

Weak to moderate affinity

kd,app or kd

Zonal elution peak fitting

Non-linear zonal elution

Weak to moderate affinity

kd,app or kd

Frontal analysis curve fitting

Non-linear frontal analysis

Moderate to strong affinity

ka,app or ka

Frontal analysis moment analysisc

Non-linear frontal analysisd

Moderate to strong affinity

ka,app or ka

Peak decay method

Non-linear zonal elution

Weak to moderate affinity

kd or k-1

Split peak method

Non-linear or linear zonal elutiond

Strong affinity

k1 or ka

a

Weak affinity, Ka < 104 M-1; moderate affinity, Ka = 104 − 106 M-1; Strong affinity, Ka > 106 M-1.

b

Symbols and abbreviations: kd, dissociation rate constant; kd,app, apparent dissociation rate; ka, association rate constant; ka,app, apparent

association rate constant; k-1, reverse mass transfer rate constant for movement of a solute from the stagnant mobile phase to the flowing mobile
phase in a column; k1, forward mass transfer rate constant for movement of a solute from the flowing mobile phase to the stagnant mobile phase.
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c
This approach refers to the analysis of frontal analysis curves through the use of Eq. (10).
d

The results in this method can be extrapolated to infinite dilution to correct for any concentration dependence in the results.
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